| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Currency Trading > Currency Trading Systems - The Major Reason Most Lose |
|
Advice You - Currency Trading Systems - The Major Reason Most Lose
If you buy a currency trading system from a vendor, chances are it won’t make money in line with its track record. Furthermore, if you test your own in most cases it wo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n’t produce the same in real time trading. Why? The answer lies in curve fitting - if you don’t know what curve fitting is, read this article and it could save you a l ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ot of money. What is curve fitting? Curve fitting is when the system rules are bent (curve fitted) to the data, to make it produce a profit. This is very similar to s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hooting blindly at a barn door with a shotgun and then drawing a bulls-eye around everyone afterwards! Curve fitting and buying a system Most of the currency trading here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe systems sold by vendors have great track records in back testing and in most instances never produce the gains in real time. A hypothetical track record is exactly tha d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t: It’s designed knowing the closing forex prices and of course it’s easy to make a profit when you know the closing price in advance. Many vendors simply make sure t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc he trading system makes money so they can sell it. They know it wont work in real time, but that doesn’t matter, their after system sales. A clue to curve fitted syst easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi em is: 1. Black box – Where the logic and rules are not revealed. 2. Optimization – This is where the data has to be bent. Clues to an optimized curve fitted system a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re - unique rules or parameters, for different market conditions or currencies. The Gamblers Illusion Of course, on a few years currency trading history there is an a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ pparent order, but just like the roulette gambler who sees number sequences repeating themselves, they will never exactly repeat in the same order again. Bending the r ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi les and curve fitting to make a currency trading system more profitable is a futile exercise. If a system is robust and based upon sound logic, it should contain only ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a a few rules and parameters and they should be applied to all currencies and all market conditions. Of course, not all vendors selling currency trading systems delibera dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod tely curve fit, like individual traders back testing their system they do it without understanding exactly what they are doing. Many individual traders I have seen, ba cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ck test their systems and make money, but they want to improve profitability, so they simply bend the system to fit the data with lots of parameters and indicators. Wh tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen en they trade it real time they lose. They would have been better off with their simpler non curve fitted system! No snap shot of trading history will produce the sam t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e patterns again – it’s an illusion as we have just seen. When back testing or looking at a system just keep the following points in mind: 1. It should be based aroun ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d trading the odds. 2. It should be simple with only a few rules or parameters. 3. It should trade all currencies the same way. 4. It should trade all market conditi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ons the same way. 5. If a track record has an absence of drawdown chances are its curve fitted, so if a hypothetical track record looks to good it probably is. Don’t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de fall into the trap of curve fitting! Curve fitting is done by the majority of trading systems sold and most traders when constructing their own fall victim to it. Cur elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ve fitting deliberate or not, is the major reason hypothetical track records that appear to give fantastic growth rates in hindsight fail miserably in real time trading tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Purchase Order Financing For Resellers and Trading Companies How to Take Advantage of Public Relations What's The Deal With Search Engines And Text Link Ads?
|